Skip to main content
. Author manuscript; available in PMC: 2011 Dec 15.
Published in final edited form as: J Surg Res. 2008 Jun 23;153(1):105–113. doi: 10.1016/j.jss.2008.05.020

Table 1.

Prevalence (%) of Demographic, Tumor, Treatment and Outcome Characteristics of the Study Population at Diagnosis, by Age and Race, 1988–2003 SEER (N=224,930).

< 40 yrs(N=13944) 40–49 yrs(N=43589) 50–64 yrs(N=74785) 65+ yrs(N=92612)
B W B W B W B W
N (%) 2196(10.8) 11748(5.7) 5020(24.6) 38569(18.9) 6846(33.5) 67939(33.2) 6362(31.1) 86250(42.2)
Demographics
Marital Status
Not Married 56.7 27.0 51.7 26.3 54.9 28.0 67.9 53.7
Married 38.3 68.4 42.2 68.5 39.2 67.1 26.4 41.6
Unknown 5.0 4.6 6.2 5.2 5.9 4.9 5.7 4.7
SEER Registry
San Fran-Oak 13.3 14.1 14.9 15.2 16.0 15.0 17.2 14.3
Connecticut 10.0 17.0 10.9 17.5 11.2 17.3 10.4 18.7
Metro Detroit 30.2 15.2 35.5 15.4 38.9 15.5 44.8 15.8
Hawaii 0.9 1.9 0.2 1.8 0.3 1.7 0.2 1.3
Iowa 1.9 12.6 1.3 11.4 1.4 12.5 1.7 16.1
New Mexico 0.5 6.9 0.6 6.4 0.8 6.5 0.7 6.0
Seattle 5.5 16.3 4.5 17.1 4.0 16.9 3.7 15.9
Utah 0.2 6.4 0.2 5.7 0.2 6.1 0.2 5.8
Metro Atlanta 37.6 9.7 32.0 9.4 27.1 8.6 21.1 6.0
Tumor Characteristics
Stage at Diagnosis
In Situ 9.1 12.0 16.3 19.5 17.0 17.3 14.2 11.6
I 17.5 27.6 24.1 32.2 28.0 39.7 30.4 43.4
II 48.2 44.4 40.1 35.5 34.8 30.5 30.6 28.6
III 12.4 7.7 8.8 5.8 8.3 4.6 8.3 5.0
IV 6.1 3.1 5.1 2.6 6.8 3.6 7.9 4.9
Unstaged 6.7 5.2 5.5 4.4 5.1 4.2 8.4 6.5
Tumor Size
<2 cm 27.6 40.9 36.6 49.1 41.6 55.5 40.4 52.6
2–5 cm 44.4 39.1 39.0 31.8 34.2 27.3 32.9 29.8
>5–10 cm 11.3 6.1 7.4 4.4 6.9 3.4 7.3 3.8
>10–25 cm 1.0 0.6 1.1 0.5 1.1 0.4 1.2 0.4
Diffuse 2.4 1.6 2.1 1.2 1.8 1.1 1.8 0.9
Unknown 13.3 11.7 13.9 13.1 14.3 12.3 16.3 12.4
Grade
1 2.9 5.2 6.8 10.2 8.9 13.7 10.3 14.5
2 18.4 23.8 22.7 28.4 24.8 30.5 26.1 31.0
3 50.5 41.3 41.4 30.5 36.4 26.0 28.5 21.8
Unknown 28.2 29.7 29.0 30.8 29.9 29.8 35.1 32.7
Node Involvement
No 47.1 55.8 57.0 65.4 59.7 68.7 57.6 66.1
Yes 44.8 38.5 36.0 30.3 32.3 26.3 26.7 21.1
Unknown 8.0 5.7 7.1 4.3 8.0 5.0 15.7 12.8
Laterality
Right 48.9 49.4 48.5 49.4 47.1 48.5 48.4 48.1
Left 50.5 50.1 51.0 50.2 52.3 51.0 50.5 50.7
Bilateral/Unknown 0.5 0.5 0.5 0.4 0.6 0.5 1.1 1.2
ER status
Neg 34.6 27.0 28.8 18.1 24.9 14.7 16.0 10.2
Pos 31.5 39.9 34.1 46.0 37.0 50.8 41.4 53.6
Unknown 33.8 33.0 37.2 35.9 38.1 34.5 42.5 36.2
PR status
Neg 36.9 29.3 30.6 20.2 30.6 21.0 23.4 18.5
Pos 28.6 36.7 31.6 42.8 30.5 42.9 33.0 43.7
Unknown 34.5 34.0 37.8 37.0 38.9 36.1 43.6 37.8
Treatment Characteristics
Radiation
No 56.5 54.4 55.4 52.0 54.2 50.6 65.6 64.1
Yes 39.1 42.9 40.2 45.5 41.9 47.5 32.0 34.6
Unknown 4.5 2.7 4.4 2.5 3.9 1.9 2.4 1.3
Surgery
No 4.6 1.9 3.6 1.9 4.5 2.3 8.2 4.6
Yes 78.9 81.2 81.3 82.6 81.1 85.2 79.0 86.0
Unknown 16.5 16.9 15.1 15.5 14.4 12.5 12.8 9.4
Outcomes
Died
Yes 31.7 18.9 23.5 12.3 26.6 14.9 45.1 38.4
No 68.3 81.1 76.5 87.7 73.4 85.1 54.9 61.6
Breast Cancer-Specific Death
Yes 27.7 17.0 19.2 10.5 19.0 10.5 19.6 13.3
No 72.3 83.0 80.8 89.5 81.0 89.5 80.4 86.7
Other Cause of Death
Yes 4.0 1.9 4.3 1.8 7.6 4.4 25.5 25.1
No 96.0 98.1 95.7 98.2 92.4 95.6 74.5 74.9

Note. B = Black; W = White; All chi-square comparisons were statistically significant except for laterality within each of the age groups, and for other cause of death within the 65+ age group.